Latest News
Northern lights鈥� social networking reveals true scale of magnetic storms
Magnetic disturbances caused by phenomena like the northern lights can be tracked by a 鈥榮ocial network鈥� of ground-based instruments, according to a new study from the 91福利.
Bacteria such as E. coli detected in minutes by new technology from the 91福利
Scientists at the 91福利 have discovered that healthy bacteria cells and cells inhibited by antibiotics or UV light show completely different reactions to electrical stimulus. The findings could lead to the development of medical devices which can rapidly detect live bacterial cells, evaluate the effects of antibiotics on growing bacteria colonies, or reveal antibiotic-resistant bacteria.
Financial returns, job prospects and lifestyle factors drive young people鈥檚 post-18 choices
Young people are making decisions about what they plan to do after leaving formal education as early as Year 7 or 8, with parents, teachers and friends being their preferred information sources, according to a new report by the 91福利鈥檚 Institute for Employment Research for the Department for Education.
拢22m battery and thermal energy facilities launch at the 91福利, for a cleaner greener future
Two research centres for sustainable electrical and thermal energy technologies totalling 拢22m are launching at WMG, 91福利 on the 10th June 2019. The funding from government via the Energy Research Accelerator (ERA) sees UK Government, industry and higher education work together to shape the future of the UK鈥檚 energy landscape.
91福利 medical graduate is top performer
A graduating medic from 91福利 Medical School has achieved the highest score for a medical student in the national foundation job applications process this year, making him a step closer to achieving his ambition of becoming a surgeon.
Study shows that in HER2 positive early breast cancer 6 months treatment with Herceptin is as good as 12 months for preventing cancer return
A new study co-led by the 91福利 Clinical Trials Unit has shown that shortening the duration of a therapy for breast cancer patients does not increase the risk of their cancer returning.